Type 2 Diabetes & Pre-Diabetes Doctor in Doral, FL

What type 2 diabetes is and how it is diagnosed

Type 2 diabetes is confirmed by at least two abnormal results — either two of the same test on separate days, or two different tests at the same visit. The ADA recommends A1C as the primary screening test for most adults because it does not require fasting; a fasting plasma glucose or oral glucose tolerance test confirms when results are borderline. Pre-diabetes is the window between normal and diabetes, defined as A1C 5.7-6.4% or fasting glucose 100-125 mg/dL. About 38% of U.S. adults have pre-diabetes per CDC 2024, and roughly 80% of those do not know it. We screen at every primary care intake for adults with risk factors — age, BMI, family history, prior gestational diabetes, polycystic ovary syndrome — and offer A1C plus fasting lipids in one lab draw.

Symptoms — often subtle until glucose is high

• Increased thirst and frequent urination, especially at night
• Unexplained weight loss or, less commonly, weight gain
• Fatigue that does not resolve with rest
• Blurred vision that fluctuates with glucose level
• Slow-healing cuts, recurrent yeast or urinary infections
• Tingling or numbness in hands and feet (later stages, peripheral neuropathy)

How we treat diabetes at Viva Medical Center in Doral

Diabetes care is more than blood sugar. The ADA 2024 Standards of Care frame diabetes as a cardiometabolic condition — meaning we treat glucose, blood pressure, cholesterol, weight, kidney function, and foot and eye health as one coordinated plan. Lifestyle change is the foundation for everyone and remains essential even when medication is added. When medication is needed, your physician will recommend a class based on your A1C, weight, cardiovascular and kidney risk, side-effect tolerance, and what your insurance covers. Common classes used per the ADA 2024 algorithm include biguanides as initial therapy for most, then GLP-1 receptor agonists or SGLT2 inhibitors when cardiovascular or kidney disease is present, with sulfonylureas, DPP-4 inhibitors, thiazolidinediones, and insulin as the situation requires. We do not name specific brands here — your physician will review options, side effects, and cost during your visit.

• Comprehensive lab panel — A1C, fasting lipids, kidney function (eGFR + urine ACR), liver, and B12 when appropriate
• Structured nutrition plan adapted to Cuban/Latin-American eating patterns
• Medication from FDA-approved antidiabetic classes selected to your profile
• GLP-1 program with prior-authorization support when criteria are met
• Insulin initiation and titration when needed, with bilingual teach-back
• Annual diabetic eye exam (retinal screening) and foot exam coordination
• Continuous glucose monitor (CGM) referral when clinically appropriate
• Coordination with endocrinology, nephrology, or cardiology when complexity warrants it

Pre-diabetes — the most important window

Pre-diabetes is not a benign label. Per CDC and ADA data, about 1 in 3 adults with pre-diabetes progress to type 2 diabetes within 5 years without intervention — but structured lifestyle change cuts that risk by 58% in the landmark Diabetes Prevention Program trial. The protocol that works: a 5-7% body-weight loss over 6 months and at least 150 minutes a week of moderate activity. We enroll qualifying patients in a structured plan, set realistic checkpoints, and re-test A1C every 6-12 months. For some patients with strong risk factors, the ADA also recommends discussing whether early metabolic medication is appropriate.

Hispanic and Latino adults face a higher diabetes burden

Per CDC 2024 data, 17% of Hispanic adults in the U.S. have diagnosed or undiagnosed diabetes — versus 13.6% of non-Hispanic White adults. The reasons are layered: genetics, central adiposity patterns, dietary culture, work patterns, and access. Doral and Miami-Dade have one of the highest concentrations of Cuban, Venezuelan, Colombian, and Caribbean-Hispanic residents in the country, which is why our diabetes program is built for it from day one — bilingual visits, food lists that include arroz con frijoles and plátanos, a glucose log that reads in Spanish, and physicians who know which carbohydrate substitutions actually work in a Latin household.

GLP-1 program — what we do and do not promise

Our GLP-1 program offers FDA-approved GLP-1 receptor agonists for adults who meet ADA criteria — typically type 2 diabetes with a need for additional A1C lowering, weight management with comorbid conditions, or established atherosclerotic cardiovascular disease. We do not promote brands or social-media trends. A real medical program means an intake evaluation, a baseline lab panel, an insurance check before any prescription, monitoring labs every 3 months while you are on therapy, a side-effect plan (nausea is common in the first 4-6 weeks), and a written off-ramp plan if therapy is paused. We follow ADA 2024 guidance on when to start, when to escalate, and when to combine with insulin or other classes.

Foot care, eye exams, and the complications we screen for

• Annual dilated retinal exam — diabetic retinopathy is a leading cause of preventable blindness
• Annual comprehensive foot exam — monofilament testing for early peripheral neuropathy plus vascular check
• Yearly urine albumin-to-creatinine ratio and eGFR — diabetic kidney disease is silent and treatable when caught early
• Blood pressure control to ADA targets — typically <130/80 for most patients with diabetes
• Lipid management with class-based therapy when LDL or cardiovascular risk warrants it
• Smoking cessation, sleep apnea screening, and dental care referral as part of cardiometabolic care

Insurance, same-day visits, and bilingual diabetes education in Doral

Viva Medical Center is in-network with the major carriers serving Miami-Dade. Diabetes office visits, A1C testing, and follow-up are covered under your primary care benefit. Diabetes education sessions, when prescribed for newly diagnosed patients, are reimbursable under most plans — our front desk verifies your specific benefit. Same-day appointments are available for new symptoms, glucose urgencies, or medication side effects.

• In-network with Oscar Health, Aetna, Cigna, Humana, Medicare Advantage, Ambetter, and UnitedHealthcare
• Same-day visits when symptoms or a glucose reading need quick attention
• Telehealth follow-ups for medication titration and lab review
• Bilingual intake, visits, telehealth, food lists, and discharge — English and Spanish
• Coordination with in-network endocrinology, nephrology, and ophthalmology when needed